- Home
- ENLV vs AMOD Comparison
ENLV vs AMOD Comparison
Compare ENLV & AMOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- AMOD
- Stock Information
- Founded
- ENLV 2005
- AMOD 2014
- Country
- ENLV Israel
- AMOD United States
- Employees
- ENLV N/A
- AMOD N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- AMOD
- Sector
- ENLV Health Care
- AMOD
- Exchange
- ENLV Nasdaq
- AMOD NYSE
- Market Cap
- ENLV 20.7M
- AMOD 16.5M
- IPO Year
- ENLV 1995
- AMOD N/A
- Fundamental
- Price
- ENLV $1.01
- AMOD $1.36
- Analyst Decision
- ENLV Strong Buy
- AMOD
- Analyst Count
- ENLV 2
- AMOD 0
- Target Price
- ENLV $10.00
- AMOD N/A
- AVG Volume (30 Days)
- ENLV 146.1K
- AMOD 181.5K
- Earning Date
- ENLV 04-11-2025
- AMOD 05-15-2025
- Dividend Yield
- ENLV N/A
- AMOD N/A
- EPS Growth
- ENLV N/A
- AMOD N/A
- EPS
- ENLV N/A
- AMOD N/A
- Revenue
- ENLV N/A
- AMOD N/A
- Revenue This Year
- ENLV N/A
- AMOD N/A
- Revenue Next Year
- ENLV N/A
- AMOD N/A
- P/E Ratio
- ENLV N/A
- AMOD N/A
- Revenue Growth
- ENLV N/A
- AMOD N/A
- 52 Week Low
- ENLV $0.81
- AMOD $1.20
- 52 Week High
- ENLV $4.59
- AMOD $13.49
- Technical
- Relative Strength Index (RSI)
- ENLV 44.89
- AMOD N/A
- Support Level
- ENLV $0.92
- AMOD N/A
- Resistance Level
- ENLV $1.13
- AMOD N/A
- Average True Range (ATR)
- ENLV 0.10
- AMOD 0.00
- MACD
- ENLV -0.01
- AMOD 0.00
- Stochastic Oscillator
- ENLV 24.32
- AMOD 0.00
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.